- Titre
- The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
- Créateurs - sans rôle
- Magali Olivier - IARC, Lyon, FranceAnita Langerød - University of OsloJennifer Varley - Paterson Institute for Cancer Research, Manchester, United KingdomYves Bignon - Department of Oncogenetics, Centre Jean Perrin, Clermont-Ferrand, FranceNancy Uhrhammer - Centre Jean PerrinRobert Winqvist - Department of Clinical Genetics, Oulu University Hospital, University of Oulu, Oulu, FinlandArja JUKKOLA-VUORINEN - Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, FinlandDieter Niederacher - OlgahospitalShunsuke Kato - Department of Clinical Oncology, Institute of Development Aging and Cancer, Aoba-ku, Sendai, JapanChikashi Ishioka - Department of Clinical Oncology, Institute of Development Aging and Cancer, Aoba-ku, Sendai, JapanPierre Hainaut - IARC, Lyon, FranceAnne-Lise BØRRESEN-DALE - University of OsloPatrizia Carrieri - INSERM U379, ORS PACA, Epidemiologie Sociale Appliquée à l'Innovation, Marseille, FranceJonas Bergh - Department of Oncology (Radiumhemmet), Karolinska Hospital and Institute, Stockholm, SwedenSigrid Klaar - Department of Oncology (Radiumhemmet), Karolinska Hospital and Institute, Stockholm, SwedenJorunn Eyfjord - University of IcelandCharles Theillet - InsermCarmen Rodriguez - INSERM E 229, CRLC Val d'Aurelle/Paul Lamarque, Montpellier, FranceRosette Lidereau - InsermIvan Bieche - Inserm
- Détails de publication
- Clinical cancer research, Vol.12(4), pp.1157-1167
- Éditeur
- American Association for Cancer Research
- Nombre de pages
- 11
- Identifiants
- 99162671309311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
Clinical cancer research, Vol.12(4), pp.1157-1167
15/02/2006
PMID: 16489069
Indicateurs
1 Consultations de la notice